Yoni Weiss

Radiation Oncologist and Brachytherapy Specialist @miamicancerinst Residency @UofTDRO Fellowship @UCLAHealth

[Michael Chuong @MikeChuongMD]

Our @MiamiCancerInst MR-Linac program began in 2018 as one of the first in the world.

Here's an overview of our pt triage & treatment patterns in the context of offering many other advanced #radonc platforms.

Online adaptive times can be feasible!

https://t.co/rEbQPwijgP

[Herbert Wertheim Cancer Institute Research @MiamiCancerInst]

We are excited to announce Dr. Jean-Marie Stephan performed the first successful uterine transposition surgery on a cancer patient in the region. This will allow future female patients, who have cancer in the pelvic region, to preserve their uterus so that they can carry a fetus to term and successfully deliver.

Learn more about this milestone here: https://t.co/K3MN4W4obu

[DrKamrava @KamravaMD]

Transrectal ultrasound for intraoperative interstitial needle guidance in cervical cancer brachytherapy https://t.co/yVkLU1PECs
you wouldn't do a prostate implant wo U/S and you shouldn't put in needles for a gyn without U/S either
#seewithsound

[DrKamrava @KamravaMD]

Brachytherapy for rectal and anal cancer: Where are we and current perspectives? - Brachytherapy https://t.co/BGwIWj976Q
Great overview of data
Rectal w chance to be managed like cervical cancer - chemo/EBRT->BT boost
easy to learn/do which is big plus
@brachyexpert

[Yoni Weiss @yoniweissmd]

@DrAndrewLoblaw HDR !

[Michael Chuong @MikeChuongMD]

We are passionate bc we have seen first hand how transformative this technology is. Critics will always have something to say. But I stand behind our published ablative data showing long-term OS with very low toxicity for unresectable tumor. Patients win if the tech lives on.

[Michael Chuong @MikeChuongMD]

It is bittersweet that the initial phase 2 SMART pancreas trial results are now in press @IJROBP as @viewray finalizes the bankruptcy process. Congrats to @radoncbme and the entire study team for completing this trial, which many doubted could be done.

https://t.co/wybUDJ13KQ

[Daniel E Spratt @DrSpratticus]

Thank you @ASTRO_org.

Horrific there are humans who decapitate babies, rape women, and more horrific things to even name. Pure evil.

To my family members called to serve in Israel, and the many others involved, I hope for your and your families safety. I hope all innocent people will be unharmed and justice will be served. Sadly I know this has never happened in history when terrorism and war involved. Innocent people already suffering due to Hamas starting this violence that has led to war and more innocent ppl suffering.

Fighting Nazis in WWII was the right thing to do, but sadly innocent people harmed in process. Blame was on Nazis. Doesn’t mean bystanders harmed wanted. Tragic.

Nothing can justify the attack by Hamas. Supporting Jews and Israelis does not mean anyone wants innocent people harmed in Gaza.

For those of us blessed with immense freedom, loving one another and respecting everyone helps prevent this from happening here. I hope this brings some perspective to how fortunate most of us are. Enough toxic negativity. Let’s support one another.

[Sushil @Sushilberiwal]

HDR boost vs EBRT on TROG less GI and more GU morbidity with HDR @KamravaMD @DrSpratticus @DrAndrewLoblaw @AmericanBrachy
@ASTRO_org
https://t.co/YwAjgklta7

[Michael Chuong @MikeChuongMD]

Despite the debate around #MRgRT its impact on #radonc is undeniable. The inability for sites to continue using #MRIdian still seems like a bad dream. But it will soon become reality and patients w/o question are those who immensely lose. What a complete and utter shame.

[Dr Kevin Martell @kevinmartell]

Dr Mendez presenting the acute toxicity results of the HOPE trial looking at 25/5 to the whole pelvis plus brachytherapy.

[Gustavo @gusviani]

🎙 SBRT retreatment for recurrent #gynaecologicalcancer is a highly feasible and safe❗️🚨@OncoAlert
📌Retro study 23 👥 / 27 lesions recurrent GY cancer retreated w/ SBRT ➕Common SBRT 30Gy/5fx
🥇🎯: OS/ Quol/Tox
📊RESULTs
👉Median FU 32m
👉N🚫 G2+ acute or late tox
👉1 and 2y LC 77.9% and 70.8%
👉1 and 2y OS 82.6% and 75.1%
👉ORR 96.0%😱
👉N🚫sig diff in QoL between baseline ✖️follow-up values👍
#radonc

[Radiotherapy & Oncology @RO_GreenJournal]

New article alert (Vol. 186)

Cine MRI-based analysis of intrafractional motion in radiation treatment planning of head and neck cancer patients
Yonatan Weiss et al.

https://t.co/5SkFh33P5g

https://t.co/9bzET0nacV

[Sushil @Sushilberiwal]

New FIGO staging taking histology and substantial LVSI into account ⁦@KamravaMD⁩ ⁦@AnnKloppMD⁩ ⁦@bindhu2102⁩ ⁦@AndrewKellerMD⁩ #gynsm

[Yoni Weiss @yoniweissmd]

love this almost as much as brachy ;)

[Michael Chuong @MikeChuongMD]

3 mets in the pancreas - head, body, and tail - individually tracked and simultaneously ablated in only 5 fractions with #MRIdianA3i. If one exceeds the gating threshold then treatment is automatically paused for all. Just incredible. @KateMRGuidance @MiamiCancerInst @viewray

[Kathryn Mittauer, PhD @KateMRGuidance]

🧲 MR-linac FSRS 🌴Miami Style! 27 Gy/3 fx 2cm brain met 🧠 with MRIdian’s A3i BrainTx treated today. Accumulation of hardwork & dedication of @MiamiCancerInst MRgRT team & collaboration/partnership with @viewray #RealtimeMR #TumorGating #CNS @Rrkotecha @OsnolaRavan @MikeChuongMD

[Yoni Weiss @yoniweissmd]

@KrishanJethwa @jryckman3 @SprakerMDPhD @olusolaodavies @ParikhSimul @drthomaskole @toddscarbrough @ndesai2005 @alongi_filippo @ChristenElledge @free_radical28 @Sushilberiwal Just brachy it at that point @KrishanJethwa 😉

[Michael Chuong @MikeChuongMD]

Excited we treated 2 online adaptive patients today with #MRIdian A3i @miamicancerinst!! The imaging and workflow improvements are 💪💪💪!! So grateful to our MR physics team led by @KateMRGuidance and strong partnership with @viewray for making this possible 🙏

[Eric Leung @leunger22]

Can the number of radiation treatments to the pelvis for uterus cancer patients be decreased from 25 down to 5? See our recent publication in JAMA Oncology - The SPARTACUS trial. #radonc #GynCSM @Sunnybrook @LHSCCanada https://t.co/hgAczLGO1l

[Yoni Weiss @yoniweissmd]

Just an oncologist watching Superbowl lymphovascular invasion (LVI) featuring the low anterior resections (LAR) vs. cervical intraepithelial neoplasias (CIN).